Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 12.716 Q1 | 254 | 22 | 66 | 7351 | 1862 | 65 | 23.55 | 334.14 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.536 Q1 | 70 | 6 | 43 | 1620 | 277 | 43 | 5.84 | 270.00 | |
3 | Reviews in Contemporary Pharmacotherapy | journal | 0.261 Q3 | 18 | 6 | 79 | 1445 | 107 | 79 | 2.28 | 240.83 | |
4 | Progress in Medicinal Chemistry | journal | 1.288 Q1 | 38 | 8 | 19 | 1459 | 55 | 6 | 3.31 | 182.38 | |
5 | Pharmacology and Therapeutics | journal | 2.763 Q1 | 233 | 55 | 189 | 9848 | 1363 | 187 | 5.89 | 179.05 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.244 Q1 | 82 | 16 | 40 | 2641 | 168 | 40 | 3.15 | 165.06 | |
7 | Annual Review of Pharmacology and Toxicology | journal | 10.621 Q1 | 224 | 33 | 65 | 4729 | 1431 | 64 | 21.27 | 143.30 | |
8 | Anti-Cancer Agents in Medicinal Chemistry | journal | 108 | 18 | 0 | 2221 | 0 | 0 | 0.00 | 123.39 | ||
9 | Expert Opinion on Therapeutic Targets | journal | 0.254 Q3 | 106 | 47 | 135 | 5636 | 70 | 135 | 0.75 | 119.91 | |
10 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 45 | 8 | 0 | 945 | 0 | 0 | 0.00 | 118.13 | ||
11 | Current Drug Targets | journal | 0.238 Q3 | 119 | 29 | 21 | 3384 | 16 | 21 | 0.76 | 116.69 | |
12 | Current Pharmaceutical Design | journal | 1.153 Q1 | 183 | 115 | 219 | 13310 | 742 | 192 | 3.17 | 115.74 | |
13 | Current Cancer Drug Targets | journal | 103 | 16 | 0 | 1772 | 0 | 0 | 0.00 | 110.75 | ||
14 | Medicinal Research Reviews | journal | 1.632 Q1 | 150 | 28 | 74 | 3075 | 382 | 73 | 5.54 | 109.82 | |
15 | CNS Drug Reviews | journal | 0.254 Q3 | 64 | 23 | 96 | 2299 | 60 | 96 | 0.61 | 99.96 | |
16 | Current Medicinal Chemistry | journal | 1.951 Q1 | 202 | 122 | 166 | 11854 | 930 | 154 | 5.79 | 97.16 | |
17 | Expert Opinion on Emerging Drugs | journal | 0.233 Q3 | 54 | 23 | 70 | 2173 | 60 | 68 | 0.89 | 94.48 | |
18 | Infectious Disorders - Drug Targets | journal | 61 | 27 | 0 | 2515 | 0 | 0 | 0.00 | 93.15 | ||
19 | Cellular and Molecular Life Sciences | journal | 2.575 Q1 | 261 | 183 | 547 | 16769 | 2344 | 533 | 4.40 | 91.63 | |
20 | Current Drug Metabolism | journal | 0.329 Q2 | 122 | 28 | 20 | 2547 | 16 | 20 | 0.80 | 90.96 | |
21 | Annual Report of Shionogi Research Laboratory | journal | 0.103 Q4 | 2 | 1 | 6 | 87 | 0 | 6 | 0.00 | 87.00 | |
22 | Expert Opinion on Biological Therapy | journal | 102 | 84 | 0 | 6963 | 0 | 0 | 0.00 | 82.89 | ||
23 | Mini-Reviews in Medicinal Chemistry | journal | 107 | 38 | 0 | 3149 | 0 | 0 | 0.00 | 82.87 | ||
24 | Drug Resistance Updates | journal | 0.727 Q1 | 132 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | |
25 | IDrugs : the investigational drugs journal | journal | 0.159 Q3 | 39 | 54 | 310 | 4189 | 71 | 306 | 0.21 | 77.57 | |
26 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 12 | 17 | 0 | 1305 | 0 | 0 | 0.00 | 76.76 | ||
27 | Drug Safety | journal | 1.019 Q1 | 140 | 86 | 238 | 6344 | 955 | 231 | 3.96 | 73.77 | |
28 | Apoptosis : an international journal on programmed cell death | journal | 0.446 Q2 | 128 | 47 | 159 | 3353 | 143 | 159 | 0.89 | 71.34 | |
29 | Expert Opinion on Pharmacotherapy | journal | 0.301 Q3 | 93 | 168 | 105 | 11843 | 123 | 104 | 1.17 | 70.49 | |
30 | BioDrugs | journal | 0.237 Q3 | 79 | 70 | 230 | 4783 | 142 | 218 | 0.58 | 68.33 | |
31 | Side Effects of Drugs Annual | book series | 0.105 Q4 | 9 | 51 | 153 | 3328 | 6 | 153 | 0.06 | 65.25 | |
32 | Cardiovascular Drug Reviews | journal | 0.299 Q3 | 54 | 25 | 80 | 1597 | 59 | 80 | 0.52 | 63.88 | |
33 | Expert Opinion on Investigational Drugs | journal | 0.521 Q2 | 117 | 357 | 580 | 22450 | 915 | 575 | 1.72 | 62.89 | |
34 | Clinical Pharmacokinetics | journal | 1.435 Q1 | 184 | 75 | 206 | 4310 | 1107 | 198 | 5.14 | 57.47 | |
35 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.552 Q2 | 150 | 102 | 291 | 5448 | 384 | 291 | 1.22 | 53.41 | |
36 | Expert Opinion on Therapeutic Patents | journal | 0.404 Q2 | 88 | 126 | 429 | 6674 | 437 | 424 | 1.02 | 52.97 | |
37 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.167 Q3 | 29 | 20 | 24 | 1058 | 8 | 22 | 0.27 | 52.90 | |
38 | Current Opinion in Investigational Drugs | journal | 0.185 Q3 | 83 | 36 | 0 | 1888 | 0 | 0 | 0.00 | 52.44 | |
39 | Food and Drug Law Journal | journal | 0.336 Q2 | 23 | 25 | 140 | 1303 | 47 | 140 | 0.22 | 52.12 | |
40 | Pharmacogenomics | journal | 0.616 Q2 | 100 | 40 | 35 | 2061 | 66 | 35 | 1.89 | 51.53 | |
41 | Antiviral Therapy | journal | 0.924 Q1 | 93 | 41 | 164 | 2087 | 329 | 147 | 2.12 | 50.90 | |
42 | Journal of International Peacekeeping | journal | 14 | 25 | 76 | 1264 | 0 | 64 | 0.00 | 50.56 | ||
43 | Neuropsychopharmacology | journal | 2.239 Q1 | 249 | 182 | 427 | 9179 | 2111 | 397 | 4.68 | 50.43 | |
44 | International Journal of Neuropsychopharmacology | journal | 0.490 Q2 | 125 | 50 | 113 | 2485 | 150 | 110 | 1.34 | 49.70 | |
45 | Current Opinion in Pharmacology | journal | 148 | 92 | 0 | 4567 | 0 | 0 | 0.00 | 49.64 | ||
46 | Drugs of the Future | journal | 0.363 Q2 | 46 | 84 | 315 | 4137 | 311 | 315 | 1.09 | 49.25 | |
47 | Clinical Research and Regulatory Affairs | journal | 0.117 Q4 | 18 | 23 | 49 | 1132 | 6 | 46 | 0.11 | 49.22 | |
48 | Journal of Cannabis Therapeutics | journal | 18 | 14 | 0 | 670 | 0 | 0 | 0.00 | 47.86 | ||
49 | International Immunopharmacology | journal | 149 | 199 | 611 | 9446 | 1035 | 597 | 1.73 | 47.47 | ||
50 | Biopharmaceutics and Drug Disposition | journal | 0.299 Q3 | 65 | 36 | 183 | 1661 | 147 | 181 | 0.86 | 46.14 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®